| Date | Title | Description |
| 03.01.2024 | Fred Duchin Joins Avista Capital Partners as a Strategic Executive | NEW YORK, NY – January 2, 2024 – Avista Capital Partners (“Avista”), a leading private equity firm focused exclusively on healthcare, today announced that Fred Duchin has joined the firm as a Strategic Executive. Mr. Duchin is the Chairman ... |
| 02.01.2024 | Probo Medical Signs Definitive Agreement to Acquire Alpha Source Group | TAMPA, Fla., Dec. 28, 2023 /PRNewswire/ — Probo Medical (“Probo”), a leading global provider of medical imaging equipment, parts, repair and service, has signed a definitive purchase agreement to acquire Alpha Source Group (“Alpha Source”) ... |
| 02.10.2023 | Cooper Consumer Health Enters Into Exclusive Negotiations with Viatris for the Acquisition of Viatris’ Over-the-Counter (OTC) Business | 2nd October 2023
Cooper Consumer Health (“Cooper CH”) a leading European independent over-the-counter drug manufacturer and distributor, is pleased to announce today that it has entered into exclusive negotiations with Viatris Inc. (“Viatr... |
| 15.06.2023 | EY Announces Apurva Saraf, President and CEO of Cosette Pharmaceuticals as an Entrepreneur Of The Year® 2023 New Jersey Award Winner | BRIDGEWATER, N.J.–(BUSINESS WIRE)–Ernst & Young LLP (EY US) today announced that Apurva Saraf, President and CEO of Cosette Pharmaceuticals was named an Entrepreneur Of The Year® 2023 New Jersey Award winner. The Entrepreneur Of The Yea... |
| 08.06.2023 | Cosette Pharmaceuticals Acquires Intrarosa® from Endoceutics, Inc. | Acquisition accelerates Cosette’s women’s health portfolio; with a differentiated, commercial stage, patent protected product
BRIDGEWATER, N.J.–(BUSINESS WIRE)–Cosette Pharmaceuticals, Inc. (“Cosette”), a US-based specialty pharmaceutical ... |
| 05.06.2023 | Solmetex, LLC Acquires Impladent LTD. | — Combination Adds Attractive Regenerative Dental Technology Products —
MARLBOROUGH, Mass. and QUEENS, N.Y., June 5, 2023 /PRNewswire/ — Solmetex, LLC, the dental industry’s leading provider of dental waterline products and modern dental i... |
| 30.05.2023 | eMolecules acquires Specs Compound Handling B.V. | Combination expands footprint offering a global one-stop shop for streamlined chemical compound procurement and management services for drug discovery chemistry researchers.
SAN DIEGO and ZOETERMEER, The Netherlands, May 25, 2023 /PRNewswi... |
| 05.05.2023 | Probo Medical Completes Acquisition of National Ultrasound | TAMPA, FL. (May 5, 2023)– Probo Medical (“Probo”), a leading global provider of medical imaging equipment, parts, repair and service, announced the acquisition of National Ultrasound, Inc. (“National”). Terms of the transaction were not dis... |
| 28.04.2023 | RVL Pharmaceuticals plc Announces Insider and Athyrium-Led Financing | BRIDGEWATER, N.J., Aug. 04, 2022 (GLOBE NEWSWIRE) — RVL Pharmaceuticals plc (Nasdaq: RVLP) (“RVL” or the “Company”), a specialty pharmaceutical company focused on the commercialization of UPNEEQ® (oxymetazoline hydrochloride ophthalmic solu... |
| 28.04.2023 | WellSpring Consumer Healthcare Acquires Iconic OTC Skin Care Brands from Bayer | Addition of A+D® and Solarcaine® bolsters scale, product diversity, and opportunities to accelerate WellSpring’s innovation pipeline
New York, NY and Sarasota, FL – April 4, 2023 – WellSpring Consumer Healthcare, a developer and marketer o... |
| 28.04.2023 | Probo Medical Acquires Ultra Select Medical | TAMPA, Fla., April 26, 2023 /PRNewswire/ — Probo Medical (“Probo”), a leading global provider of medical imaging equipment, parts, repair and service, announced today the acquisition of Ultra Select Medical, LLC (“Ultra Select”). Terms of t... |
| 24.12.2022 | AVISTA CAPITAL PARTNERS ACQUIRES SPEAR EDUCATION | Avista to leverage expertise in the healthcare technology sector and dental end-market to support Spear’s growth ambitions
NEW YORK, Dec. 19, 2022 /PRNewswire/ — Avista Capital Partners (“Avista”), a leading private equity firm focused exc... |
| 10.11.2022 | UBC Appoints Bekki Brown President & Chief Executive Officer | Effective January 1, 2023, Bekki Brown will assume the role of President & Chief Executive Officer of UBC
BLUE BELL, P.A., November 10, 2022 – UBC, a biopharmaceutical leader providing integrated clinical, safety, and commercialization... |
| 02.11.2022 | OmniAb Announces Completion of Spin-Off and Business Combination | Leading Antibody Discovery Technologies Enable Development of Innovative Therapeutics
Regular-way Trading of OABI Begins November 2, 2022 on Nasdaq
EMERYVILLE, Calif. (November 1, 2022) – OmniAb, Inc. (NASDAQ: OABI) today announced the co... |
| 01.11.2022 | Avista Capital Partners Acquires Taconic Biosciences | Avista to leverage industry expertise to support Taconic’s growth in the large and expanding GEMs market
NEW YORK, November 1, 2022 — Avista Capital Partners (“Avista”), a leading private equity firm focused exclusively on healthcare, toda... |
| 28.10.2022 | Vision Healthcare announces the acquisition of AixSwiss, a fast-growing and market-leading probiotic nutraceuticals omnichannel player, active under the Nupure brand in the DACH markets | About the Acquisition
Vision Healthcare reached an agreement with the shareholders of AixSwiss BV for the acquisition of 100% of the shares in AixSwiss BV (“AixSwiss” or the “Company”), a leading DACH e-commerce player active in probiotic ... |
| 11.10.2022 | Avista Public Acquisition Corp. II Announces Effectiveness of Registration Statement and Sets Date for Extraordinary General Meeting to Vote on Proposed Business Combination | Extraordinary General Meeting of APAC Shareholders to Vote on Proposed Business Combination with OmniAb to be Held on October 24, 2022
NEW YORK (October 3, 2022) – Avista Public Acquisition Corp. II (NASDAQ: AHPA) (“APAC”) announced today ... |
| 08.09.2022 | eMolecules acquires Frontier Scientific Inc. and Frontier Agricultural Sciences Inc. | Combination establishes a one-stop shop for efficient end-to-end solutions that facilitate chemical compound procurement and management for highly specialized chemists
SAN DIEGO and NEWARK, Del., Sept. 7, 2022 /PRNewswire/ — eMolecules, In... |
| 25.08.2022 | Avista Capital Partners Acquires WellSpring Consumer Healthcare | Avista to leverage its expertise and resources to accelerate WellSpring’s growth trajectory for the benefit of all stakeholders
NEW YORK, August 23, 2022 — Avista Capital Partners (“Avista”), a leading private equity firm focused exclusive... |
| 16.08.2022 | Probo Medical Acquires Mi Healthcare | TAMPA, Fla.– Probo Medical (“Probo”), a leading global provider of medical imaging equipment, parts, repair, and service, announced the acquisition of Mi Healthcare. Terms of the transaction were not disclosed.
Established in 1995, Mi Heal... |
| 07.08.2022 | RVL Pharmaceuticals plc Announces Insider and Athyrium-Led Financing | BRIDGEWATER, N.J., Aug. 04, 2022 (GLOBE NEWSWIRE) — RVL Pharmaceuticals plc (Nasdaq: RVLP) (“RVL” or the “Company”), a specialty pharmaceutical company focused on the commercialization of UPNEEQ® (oxymetazoline hydrochloride ophthalmic solu... |
| 03.08.2022 | UBC ANNOUNCES ACQUISITION OF EXAMOTO, LLC | With this acquisition, UBC provides the most comprehensive REMS services and innovative risk mitigation solutions for the biopharmaceutical industry
BLUE BELL, Pa., July 28, 2022 /PRNewswire/ — UBC, a biopharmaceutical leader providing int... |
| 29.06.2022 | Optinose Announces Positive Top-line Results of ReOpen2, its second Phase 3 Clinical Trial of XHANCE for Treatment of Chronic Sinusitis | First Ever Phase 3 Program to Show Improvement in Both Symptoms and Inflammation Inside the Sinuses with a Nasal Therapy for Chronic Sinusitis Patients
Physicians Diagnose Chronic Sinusitis 10 Times More Frequently Than XHANCE’s Current Na... |
| 27.04.2022 | Avista Capital Partners Completes Sale Of Inform Diagnostics to Fulgent Genetics, Inc. | NEW YORK, April 27, 2022 — Avista Capital Partners (“Avista”), a leading private equity firm focused exclusively on healthcare, today announced that it has closed on the sale of Inform Diagnostics (“Inform Diagnostics”) to Fulgent Genetics ... |
| 20.04.2022 | Fulgent Genetics Agrees to Acquire Inform Diagnostics and Provides Preliminary First Quarter Revenue Results | Proposed acquisition will add diagnostic offerings, including hematopathology and anatomic pathology, while also providing a highly complementary nationwide commercial infrastructure to support Fulgent’s rapidly expanding genomic testing fo... |
| 05.04.2022 | SOLMETEX, LLC ACQUIRES STERISIL, INC. | — Combined Company Poised to Transform the Dental Water Treatment Category, Drive Innovation, and Improve Safety —
NORTHBOROUGH, Mass. and PALMER LAKE, Colo., April 5, 2022 /PRNewswire/ — Solmetex, LLC, the dental industry’s leading provid... |
| 04.04.2022 | Probo Medical Acquires Canute Medical | TAMPA, Fla., April 4, 2022 /PRNewswire/ — Probo Medical (“Probo”), a leading global provider of medical imaging equipment, parts, repair and service, today announced the completion of its acquisition of Canute Medical (“Canute”). Terms of t... |
| 29.03.2022 | Ligand To Spin-Off Its OmniAb Business Through Merger With Avista Public Acquisition Corp. II | Transaction will result in OmniAb becoming an independent publicly-traded company
Ligand’s shareholders to receive 100% of Ligand’s shares in OmniAb through a tax-free distribution immediately prior to the merger
EMERYVILLE, Calif. & ... |
| 10.03.2022 | Neil Ferguson Joins Avista Capital Partners as a Strategic Executive | NEW YORK, NY – March 10, 2022 – Avista Capital Partners (“Avista”), a leading private equity firm focused exclusively on healthcare, today announced that Neil Ferguson has joined the firm as a Strategic Executive.
Mr. Ferguson is a proven ... |
| 09.03.2022 | UBC Announces Acquisition of MarketShare Movers (“MSM”) | BLUE BELL, Pa., March 9, 2022 /PRNewswire/ — UBC announced today that it has acquired MarketShare Movers (“MSM”), a data-driven prescription drug benefit and affordability company. As prescription drug affordability continues to be a leadin... |
| 08.03.2022 | Optinose Reports Positive Top-line Results in ReOpen1, a Landmark Phase 3 Trial for XHANCE in Chronic Sinusitis | XHANCE met both co-primary endpoints in the ReOpen1 trial, demonstrating statistically significant benefits on symptoms and CT scans in patients with chronic sinusitis
There are no FDA-approved drug treatments for the 30 million adults in ... |
| 15.02.2022 | Avista Capital Partners to Acquire Probo Medical | New York, NY and Tampa, FL — February 15, 2022 — Avista Capital Partners (“Avista”), a leading private equity firm focused exclusively on healthcare, and Probo Medical, LLC (“Probo” or “the Company”) today announced that Avista has entered ... |
| 29.01.2022 | Private Equity Industry’s First-Ever ESG Data Convergence Project Announces Milestone Commitment of Over 100 LPs and GPs | Global LPs and GPs representing $8.7 trillion USD in AUM and more than 1,400 private companies commit to collaborative ESG reporting system in its inaugural year
January 28th, 2022 – Since its launch in September 2021, the ESG Data Converg... |
| 29.01.2022 | Osmotica Pharmaceuticals plc Announces Corporate Name Change to RVL Pharmaceuticals plc, New Ticker Symbol “RVLP,” Plans to Launch UPNEEQ® into the Medical Aesthetics Market, and Provides Fourth Quart... | BRIDGEWATER, N.J., Jan. 19, 2022 (GLOBE NEWSWIRE) — Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“OSMT” or the “Company”), a specialty pharmaceutical company, announced today that the Company has changed its name to RVL Pharmaceuticals plc ... |
| 20.01.2022 | Cosette Pharmaceuticals Acquires Rights to Eight Branded Products from Daiichi Sankyo | Transformational Transaction Diversifies Cosette’s Business to Accelerate Future Growth
BRIDGEWATER, NJ – JANUARY 18, 2022: Cosette Pharmaceuticals, Inc., a New Jersey-based specialty pharmaceutical company, announced today that it has clo... |
| 13.01.2022 | Avista Capital Partners Announces Promotions | Amanda Heravi, Ben Silbert, and John Cafasso to Become Managing Directors
Anthony Russo to Assume Role of Director, Accounting and Operations
NEW YORK, January 5, 2022 /PRNewswire/ — Avista Capital Partners (“Avista”), a leading private e... |
| 15.06.2021 | Braeburn Resubmits New Drug Application for BRIXADI™ (buprenorphine) Extended-Release Subcutaneous Injection for Moderate to Severe Opioid Use Disorder | Plymouth Meeting, Pa. – June 15, 2021 – Braeburn announces that today the New Drug Application (NDA) for BRIXADI (buprenorphine) extended-release injection for subcutaneous (SC) use (CIII) for moderate to severe opioid use disorder was resu... |
| 01.04.2021 | Acino completes acquisition of select portfolio of prescription pharmaceutical products and food supplements from IlmixGroup group of companies in Russia | Zurich, Switzerland and Moscow, Russia, 1 April 2021 – Acino announced today the completion of the acquisition of select portfolio of brands from the IlmixGroup group of companies in Russia. The transaction includes eight prescription pharm... |
| 12.03.2021 | Charterhouse Capital Partners enters into exclusive negotiations for the sale of Cooper | London, 12th March 2021: Charterhouse Capital Partners LLP (“Charterhouse”), one of the longest established private equity firms operating in Europe, announces today that it has entered into exclusive negotiations for the sale of a majority... |
| 05.01.2021 | Wing Liu | Wing Liu is a Senior Accountant at Avista Capital Partners. Mrs. Liu joined Avista Capital Partners in 2014 and is a Certified Public Accountant. She received her M.S. in Accounting from Baruch College of the City University of New York. |
| 05.01.2021 | Melissa Imperiale | Melissa Imperiale is an Associate, Investor Relations at Avista Capital Partners. Ms. Imperiale joined Avista Capital Partners in 2017. Prior to joining Avista, Ms. Imperiale worked in the Equity Portfolios group at Bloomberg L.P. Ms. Imper... |
| 05.01.2021 | Roshni Charles | Roshni Charles is the Tax Director at Avista Capital Partners. Ms. Charles joined Avista Capital Partners in 2014. Prior to joining Avista, Ms. Charles was the Tax Manager at Apax Partners, where she was responsible for the tax compliance a... |
| 05.01.2021 | John Cafasso | John Cafasso is the Chief Financial Officer at Avista Capital Partners. Mr. Cafasso joined Avista Capital Partners in 2011. Prior to joining Avista, Mr. Cafasso was a Director at Credit Suisse in the asset management division. He joined Cre... |
| 05.01.2021 | Jeremy Konyves | Jeremy Konyves is a Fund Controller at Avista Capital Partners. Mr. Konyves joined Avista Capital Partners in 2013. Prior to joining Avista, Mr. Konyves worked as an Investment Controller at State Street Corporation and as an Accounting Sup... |
| 05.01.2021 | Hector Cortes | Hector Cortes is the Management Company Controller at Avista Capital Partners. Mr. Cortes joined Avista Capital Partners in 2013. Prior to joining Avista, Mr. Cortes worked as the Controller at Peconic Partners LLP. Prior to Peconic, he was... |
| 05.01.2021 | Anthony Russo | Anthony Russo is the Controller at Avista Capital Partners. Mr. Russo joined Avista Capital Partners in 2007 and is a Certified Public Accountant. Prior to joining Avista, Mr. Russo was a Senior Auditor at Eisner LLP.
Mr. Russo received a ... |
| 05.01.2021 | Seth Morgan | Seth Morgan is a Senior Accountant at Avista Capital Partners. Mr. Morgan joined Avista Capital Partners in 2016 and is a Certified Public Accountant. Prior to joining Avista, Mr. Morgan was a Senior Auditor in the Investment Management sec... |
| 05.01.2021 | Amanda Heravi | Amanda Heravi is Head of Investor Relations at Avista Capital Partners. Ms. Heravi was one of the founding members of Avista Capital Partners in 2005. Prior to Avista, Ms. Heravi was the Director of Finance and Administration at Dorset Capi... |
| 05.01.2021 | Ben Silbert | Ben Silbert is Chief Administrative Officer & General Counsel at Avista Capital Partners. Mr. Silbert was one of the founding members of Avista Capital Partners in 2005. Prior to Avista, Mr. Silbert was at DLJMB from 2001 to 2005. He ad... |
| 20.11.2020 | Eddie Zhao | Eddie Zhao is an Associate at Avista Capital Partners. Mr. Zhao joined Avista Capital Partners in 2019. Prior to joining Avista, Mr. Zhao worked as an analyst at Wells Fargo Securities in the Financial Sponsors Group. Mr. Zhao received a B.... |
| 20.11.2020 | Sam Leno | Sam Leno is an operating executive at Avista Capital Partners. Mr. Leno was retained by Avista Capital Partners in 2018. Mr. Leno is a strategic executive with more than 40 years of experience with complex multinational companies. He most r... |
| 20.11.2020 | William E. Klitgaard | William E. Klitgaard is an operating executive at Avista Capital Partners. Mr. Klitgaard was retained by Avista Capital Partners in 2020. Mr. Klitgaard has over two decades of experience leading and advising healthcare businesses in the Hea... |
| 20.11.2020 | Robert O’Neil | Robert O’Neil is an operating executive at Avista Capital Partners. Mr. O’Neil was retained by Avista Capital Partners in 2015. Mr. O’Neil has more than 35 years of operational and strategic business leadership experience and a proven track... |
| 20.11.2020 | Alex Yu | Alex Yu is a Principal at Avista Capital Partners. Mr. Yu joined Avista Capital Partners in 2017. Prior to joining Avista, Mr. Yu worked in the Private Equity Group at Goldman Sachs. Prior to joining Goldman Sachs, he worked as an Associate... |
| 20.11.2020 | Garrett Lustig | Garrett Lustig is a Vice President at Avista Capital Partners. Mr. Lustig joined Avista Capital Partners in 2015. Prior to joining Avista, Mr. Lustig worked as an investment banking analyst at Centerview Partners. Mr. Lustig received a B.S.... |
| 20.11.2020 | Isabelle Wechsler | Isabelle Wechsler is an Associate at Avista Capital Partners. Ms. Wechsler joined Avista Capital Partners in 2019. Prior to joining Avista, Ms. Wechsler worked as an analyst at Moelis & Company. Ms. Wechsler received a B.S. from Duke Un... |
| 20.11.2020 | Samson Soon | Samson Soon is an Associate at Avista Capital Partners. Mr. Soon joined Avista Capital Partners in 2020. Prior to joining Avista, Mr. Soon worked as an analyst at Lazard in the Power, Energy & Infrastructure group. Mr. Soon received a B... |
| 20.11.2020 | Joshua Tamaroff | Joshua Tamaroff is a Principal at Avista Capital Partners. Mr. Tamaroff joined Avista Capital Partners in 2009. Prior to joining Avista, Mr. Tamaroff worked as an Analyst in the leveraged finance group at Lehman Brothers and Barclays Capita... |
| 20.11.2020 | Steve Schiess | Steve Schiess is an operating executive at Avista Capital Partners. Mr. Schiess was retained by Avista Capital Partners in 2020. Mr. Schiess is a veteran executive with over 30 years of operational, marketing and sales experience in the den... |
| 20.11.2020 | Charles Harwood | Charles Harwood is an operating executive at Avista Capital Partners. Mr. Harwood was retained by Avista Capital Partners in 2007 and has been an operator in the clinical diagnostics and pharmaceutical services industries. He has nearly 30 ... |
| 20.11.2020 | Ryan Moran | Ryan Moran is a Vice President at Avista Capital Partners. Mr. Moran joined Avista Capital Partners in 2018. Prior to joining Avista, Mr. Moran was an Associate at Morgan Stanley Capital Partners where he focused on private equity investmen... |
| 20.11.2020 | Brian Markison | Brian Markison is an operating executive at Avista Capital Partners. Mr. Markison was retained by Avista Capital Partners in 2012. Mr. Markison is a seasoned executive with more than 30 years of operational, marketing, commercial developmen... |
| 20.11.2020 | Zach Kushner | Zach Kushner is an Associate at Avista Capital Partners. Mr. Kushner joined Avista Capital Partners in 2018. Prior to joining Avista, Mr. Kushner worked as an analyst at Moelis & Company. Mr. Kushner received a B.S. in Applied Economics... |
| 20.11.2020 | Katie Costello | Katie Costello is a Vice President at Avista Capital Partners. Ms. Costello joined Avista Capital Partners in 2020. Prior to joining Avista, Ms. Costello worked at Acon Investments where she focused on private equity investments across a ra... |
| 15.10.2020 | Arcadia Consumer Healthcare Acquires NATURELO®, a Premium Vitamins, Minerals and Supplements Brand | New York, NY – October 15, 2020 – Arcadia Consumer Healthcare, Inc., a recognized leader in the consumer healthcare market for over-the-counter medicines, today announced that it has completed the acquisition of NATURELO®, a premium brand o... |
| 22.09.2020 | XIFIN Executives Expect 15% Increase in Fall COVID-19 Testing Volumes; Seeing Regional Labs Pick Up Overflow from Larger, National Players | SAN DIEGO, Calif., – September 22, 2020 – COVID-19 has impacted diagnostic volumes, mix and reimbursement for a variety of diagnostic providers. As the nation transitions into fall, new challenges will arise for the laboratory industry as s... |
| 14.07.2020 | Cosette Pharmaceuticals Appoints Seasoned Industry Executive Apurva Saraf as President and Chief Executive Officer | Bridgewater, NJ, July 14, 2020 – Cosette Pharmaceuticals, Inc. (“Cosette” or the “Company”), a privately held specialty generic pharmaceutical company primarily focused on extended topical and suppository products, announced today the appoi... |
| 01.06.2020 | Avista Capital Partners and VHC Investco Acquire Vision Healthcare NV In A Transaction Valued At $336 Million | New York, NY – June 1, 2020 – Avista Capital Partners (“Avista”), a leading healthcare private equity firm, along with VHC Investco and company management, today announced the acquisition of Vision Healthcare NV (“Vision”), one of Europe’s ... |
| 04.03.2019 | New Study Shows PuraPly® Antimicrobial Positively Impacts Course of Healing Across Variety of Wound Types | Canton, MA, March 4, 2019 – Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture and commercialization of product solutions for the Advanced Wound Care and Surgical and ... |
| 10.12.2018 | Organogenesis Holdings Inc. Announces Completion of Merger of Avista Healthcare Public Acquisition Corp. and Organogenesis Inc. | Canton, MA and New York, NY, December 10, 2018 – Organogenesis Holdings Inc. (“ORGO”), a leading regenerative medicine company focused on the development, manufacture and commercialization of product solutions for the Advanced Wound Care, S... |
| 19.02.2018 | FDA Approves Osmotica Pharmaceutical’s Once-Daily OSMOLEX ER™ (amantadine) extended-release tablets for the treatment of Parkinson’s Disease and Drug-Induced Extrapyramidal Reactions in Adults | Bridgewater, NJ – February 19, 2018 – Osmotica Pharmaceutical US LLC (“Osmotica” or the “Company”), a privately-held specialty pharmaceutical company developing novel central nervous system (CNS) treatments utilizing its proprietary osmotic... |
| 08.02.2018 | BC Partners to acquire Zest Dental Solutions from Avista Capital Partners | NEW YORK, NY / LONDON, UK – February 8, 2018 – Funds advised by BC Partners (“BC Partners”), a leading international investment firm, today announced the signing of a definitive agreement whereby BC Partners will acquire Zest Dental Solutio... |
| 10.01.2018 | Braeburn Announces Completion of $110 Million Financing | Princeton, N.J.— January 10, 2018 — Braeburn Pharmaceuticals, Inc. (Braeburn) today announced that the Company has completed a $110 million mezzanine round of financing led by Wellington Capital Management. Other new investors participating... |
| 27.11.2017 | Avista Capital Partners to Acquire United BioSource | St. Louis and New York, November 27, 2017 – Express Scripts (NASDAQ: ESRX) and Avista Capital Partners, a leading private equity firm, announced today that Avista has signed a definitive agreement to acquire United BioSource (UBC), a wholly... |
| 20.11.2017 | Avista Capital Partners Completes Acquisition of Miraca Life Sciences | IRVING, Texas and NEW YORK, Nov. 20, 2017 – /PRNewswire/ — Avista Capital Partners (“Avista”), a leading private equity firm, today announced the completion of its acquisition of Miraca Life Sciences (“MLS” or the “Company”) from Miraca Hol... |
| 17.10.2017 | Optinose Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares of Common Stock | Yardley, PA, Oct. 17, 2017 – OptiNose, Inc. (NASDAQ:OPTN), a specialty pharmaceutical company focused on the development and commercialization of products for patients treated by ear, nose and throat (ENT) and allergy specialists, today ann... |
| 22.09.2017 | Avista Capital Partners to Acquire Miraca Life Sciences | IRVING, TX, NEW YORK, NY, and TOKYO, September 22, 2017 – Avista Capital Partners (“Avista”), a leading private equity firm, and Miraca Holdings Inc. (“MHD”) announced today that Avista has signed a definitive agreement to acquire Miraca Li... |
| 18.09.2017 | Optinose Announces FDA Approval of XHANCE™ (fluticasone propionate) Nasal Spray for the Treatment of Nasal Polyps | XHANCE uses Optinose® Exhalation Delivery System to uniquely deposit a proven steroid in areas of inflammation deep in the nose
FDA approval based on five clinical trials evaluating over 1,500 adult patients
Availability in the U.S. expecte... |
| 28.06.2017 | Trimb acquires well-established OTC products in Europe | Stockholm, June 28th 2017 – (Business Wire) – Trimb Healthcare AB (“Trimb”) has acquired a portfolio of well-established European OTC products from Cilag GmbH International and Janssen Pharmaceutica NV (collectively, “J&J”). The product... |
| 14.06.2017 | Lantheus Holdings, Inc. Announces Public Secondary Offering by Selling Stockholders of 3,000,000 Shares of Common Stock | North Billerica, MA, June 14 2017 – (Business Wire) – Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ:LNTH), today announced an agreement to sell 3,000,000 shares of its common stock to be offered by certain of its existing st... |
| 05.06.2017 | Avista Capital Partners has Acquired National Spine & Pain Centers | Rockville, MD and New York, June 5, 2017 /PRNewswire/ — Avista Capital Partners (“Avista”), a leading private equity firm, and National Spine & Pain Centers, LLC (“NSPC” or “the Company”) announced that Avista has acquired NSPC from Sen... |
| 09.05.2017 | OptiNose Raises $37 Million in Series D Funding Led by Fidelity | Yardley, PA, May 9, 2017 – (Business Wire) – OptiNose, a commercial-stage ENT / Allergy specialty pharmaceutical company, today announced that it has closed a $37 million Series D financing led by Fidelity Management and Research Company wi... |
| 05.05.2017 | Lantheus Holdings, Inc. Announces Public Secondary Offering by Selling Stockholders of 3,000,000 Shares of Common Stock | North Billerica, MA, May 5, 2017 – (Business Wire) – Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ:LNTH), today announced an agreement to sell 3,000,000 shares of its common stock to be offered by certain of its existing sto... |
| 06.04.2017 | AngioDynamics Announces Pricing of Secondary Offering by Selling Stockholders | Albany, NY, April 06, 2017 – (GLOBE NEWSWIRE) — AngioDynamics, Inc. (NASDAQ:ANGO) (the “Company”), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, ... |
| 28.03.2017 | Avista and Nordic Capital announce the proposed sale of a 19.95% shareholding in ConvaTec Group Plc to Novo A/S (the investment holding company of the Novo Nordisk Foundation) and a proposed placing o... | March 28, 2017 – Nordic Capital and Avista (each as defined below) have today agreed the sale of a 19.95% shareholding (the “Sale”) in ConvaTec Group Plc (“ConvaTec”) to Novo A/S, the investment holding company in the Novo group, responsibl... |
| 13.03.2017 | Lantheus Holdings, Inc. Announces Public Secondary Offering of 3,000,000 Shares of Common Stock by Selling Stockholders | North Billerica, MA, March 13, 2017 – (Business Wire) – Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ:LNTH), today announced an agreement to sell 3,000,000 shares of its common stock to be offered by certain of its existing ... |
| 28.02.2017 | Acino to acquire Litha Healthcare in South Africa | Zurich, February 28, 2017 – Acino signed a deal with certain subsidiaries of Endo International plc to acquire Litha Healthcare in South Africa.
Litha Healthcare, headquartered in Midrand, Johannesburg, is a pharma group with around 160 em... |
| 31.01.2017 | OptiNose Announces FDA Acceptance for Filing of the New Drug Application for OPN-375 | Yardley, PA, January 31, 2017 – OptiNose™ today announced the U.S. Food and Drug Administration (FDA) has accepted for review the company’s New Drug Application (NDA) for the investigational new product OPN-375. OptiNose is seeking marketin... |
| 15.11.2016 | Lantheus Holdings, Inc. Announces Upsize of Public Offering to 3,500,000 Shares of Common Stock | N Billerica, MA, Nov. 15, 2016 – BUSINESS WIRE)– Lantheus Holdings, Inc.(“Lantheus” or the “Company”) (NASDAQ:LNTH), today announced that certain of its existing stockholders (the “Selling Stockholders”) intend to increase the amount of sha... |
| 10.10.2016 | Avista Healthcare Public Acquisition Corp. Announces Pricing of $300,000,000 Initial Public Offering | NEW YORK, NY, October 10, 2016 – Avista Healthcare Public Acquisition Corp. (the “Company”), a blank check company formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, reorganization or simila... |
| 20.09.2016 | ConvaTec Rated #1 in Corporate Reputation by Patient Groups and 180 Medical Receives Award for High Integrity and Ethics | Independent survey of patient groups rates ConvaTec #1 overall for corporate reputation in the Medical Device industry
ConvaTec U.S. subsidiary company 180 Medical receives Better Business Bureau recognition and named to Best Places to Work... |
| 16.08.2016 | INC Research Announces Secondary Offering and Repurchase of Common Stock | Raleigh, N.C., August 16, 2016 – (GLOBE NEWSWIRE) — INC Research Holdings, Inc.(Nasdaq:INCR) (the “Company”), a leading global Phase I to Phase IV contract research organization, today announced that certain of its existing stockholders, na... |
| 11.08.2016 | Lantheus Holdings Announces Divestiture of Its Australian Radiopharmacy Servicing Business and Entry into Long-Term Supply and Distribution Agreement | North Billerica, MA, August 11, 2016 .–(BUSINESS WIRE)– Lantheus Holdings, Inc.(“Lantheus” or the “Company”) (NASDAQ: LNTH), parent company of Lantheus Medical Imaging, Inc. (“LMI”), a global leader in the development, manufacture and comme... |
| 01.08.2016 | INC Research Announces Secondary Offering | Raleigh, N.C., August 1, 2016 – (GLOBE NEWSWIRE) — INC Research Holdings, Inc. (Nasdaq: INCR) (the “Company”), a leading global Phase I to Phase IV contract research organization, today announced that certain of its existing stockholders, n... |
| 25.07.2016 | Acino divests its patch business to Luye Pharma Group Ltd. | Zurich – July 25, 2016 – Today Acino International AG and Acino Pharma AG (together “Acino”) have signed a definitive agreement with Luye Pharma Group Ltd. (“Luye”) to sell Acino’s transdermal patch and implant businesses. The divestment in... |
| 07.07.2016 | Partners Group and Avista Capital Partners sell Strategic Partners, Inc., the leading US supplier of healthcare apparel | July 7, 2016 – Partners Group, the global private markets investment manager, and Avista Capital Partners (“Avista”), a leading US private equity firm, have sold their interest in Strategic Partners, Inc. (“Strategic Partners”), the leading... |
| 02.05.2016 | INC Research Announces Secondary Offering | Raleigh, N.C., May 2, 2016 – INC Research Holdings, Inc. (Nasdaq:INCR) (the “Company”), a leading global Phase I to Phase IV contract research organization, today announced that certain of its existing stockholders, namely affiliates of Avi... |
| 11.03.2016 | Trimb acquires OTC products from CCS | Stockholm, March 11, 2016 – Trimb Healthcare AB (“Trimb”) has acquired CCS Healthcare AB’s (“CCS”) OTC pharmaceutical products in the Nordics. The products, which include Cortimyk (treatment of foot fungus), Hydrokortison CCS (treatment of ... |
| 28.01.2016 | OptiNose Announces FDA Approval for ONZETRA™ Xsail™ (sumatriptan nasal powder), a New Treatment for Acute Migraine Using Bi-Directional™ Breath Powered® Technology | Yardley, PA, January 28, 2016 – OptiNose, a privately-held specialty biopharmaceutical company, today announced that its licensing partner, Avanir Pharmaceuticals, Inc. has reported that the U.S. Food & Drug Administration (FDA) approve... |
| 04.12.2015 | Vertical / Trigen Holdings, LLC and Osmotica Holdings Corp Limited to Combine, Creating World-Class, Fully-Integrated Specialty Pharmaceuticals Company | SAYREVILLE, N.J. and MARIETTA, GA., December 4, 2015 – Vertical / Trigen Holdings, LLC (“Vertical / Trigen”) and Osmotica Holdings Corp Limited (“Osmotica”) today announced that they have entered into a definitive agreement to combine, crea... |
